| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |